Voss Capital’s Evolus EOLS Stock Holding History

Voss Capital’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-92,300	Closed	-$1.12M	–	93
2019 Q4	$1.12M	Buy	+92,300	New	+$1.3M	0.17%	69

Other funds holding EOLS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voss Capital's EOLS Position: Q1 2020 in Review

Voss Capital sold out of Evolus (EOLS) in Q1 2020, closing a stake of 92,300 shares — an estimated $1.12M sold.

Voss Capital first reported a position in EOLS in Q4 2019 and held it in 1 quarter. The position peaked at $1.12M in Q4 2019. 105 funds tracked by Wall St. Rank hold EOLS as of Q1 2020.

Voss Capital reported no remaining Evolus position as of Q1 2020 after selling out during the quarter.
Voss Capital sold 92,300 Evolus shares in Q1 2020, an estimated $1.12M.
Voss Capital first reported a position in Evolus in Q4 2019 and held it in 1 quarter.
Voss Capital's Evolus position peaked at $1.12M in Q4 2019.
105 funds tracked by Wall St. Rank held Evolus as of Q1 2020.

Based on Voss Capital's 13F filing for Q1 2020, filed 15 May 2020.